<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">WJCR</journal-id><journal-title-group><journal-title>World Journal of Cancer Research</journal-title></journal-title-group><issn pub-type="epub">2164-9049</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.12677/WJCR.2019.94016</article-id><article-id pub-id-type="publisher-id">WJCR-32681</article-id><article-categories><subj-group subj-group-type="heading"><subject>WJCR20190400000_17584860.pdf</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>医药卫生</subject></subj-group></article-categories><title-group><article-title>
 
 
  胃癌病理分期与长链非编码lncRNA表达的相关性研究
  Study on the Correlation between Pathological Staging of Gastric Carcinoma and Expressions of Long-Chain Non-Coding lncRNA
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>高</surname><given-names>希春</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>钱</surname><given-names>军</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>魏</surname><given-names>铭</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>徐</surname><given-names>星榕</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>汪</surname><given-names>如荣</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>辛</surname><given-names>向斌</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>河西学院附属张掖人民医院，甘肃 张掖</addr-line></aff><aff id="aff1"><addr-line>null</addr-line></aff><pub-date pub-type="epub"><day>24</day><month>10</month><year>2019</year></pub-date><volume>09</volume><issue>04</issue><fpage>110</fpage><lpage>117</lpage><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  
    目的：探讨长链非编码RNA(long noncoding RNA, lncRNA)中的lncRNA-19、FER1L4、LINC00152及AK054979在胃癌组织的表达。方法：收集24例胃癌患者癌组织，采用实时荧光定量PCR测定胃癌组织、癌旁组织及正常组织中lncRNA-19、FER1L4、LINC00152及AK054979的表达水平，分析lncRNA-19、FER1L4、LINC00152及AK054979表达与胃癌组织表达的相关性。结果：胃癌组织中lncRNA-19、FER1L4、LINC00152及AK054979的表达水平呈高表达(P均 &lt; 0.01)；且与胃癌临床病理分期呈正相关(P &lt; 0.05)。结论：lncRNA-19、FER1L4、LINC00152及AK054979在胃癌组织中均高表达，且与胃癌病理分期呈正相关。
    Objective: To explore the expression of lncRNA-19, FER1L4, LINC00152 and AK054979 in long noncoding RNA (lncRNA) in gastric carcinoma. Methods: We collected 24 cases gastric carcinoma tissues. The expression levels of lncRNA-19, FER1L4, LINC00152 and AK054979 in gastric carcinoma tissues, para-cancer tissues and normal tissues were measured by real-time fluorescence quantitative PCR, and the correlation between the expressions of lncRNA-19, FER1L4, LINC00152 and AK054979 and gastric carcinoma tissues was analyzed. Results: lncRNA-19, FER1L4, LINC00152 and AK054979 were highly expressed in gastric cancer tissues (P &lt; 0.01). It was positively correlated with the clinical pathological stages of gastric carcinoma (P &lt; 0.05). Conclusion: lncRNA-19, FER1L4, LINC00152 and AK054979 were all highly expressed in gastric carcinoma tissues and positively correlated with the pathological stages of gastric cancer. 
  
 
</p></abstract><kwd-group><kwd>胃癌，长链非编码RNA，lncRNA-19，FER1L4，LINC00152，AK054979, Gastric Cancer</kwd><kwd> Long Non-Coding RNA</kwd><kwd> lncRNA-19</kwd><kwd> FER1L4</kwd><kwd> LINC00152</kwd><kwd> AK054979</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>胃癌病理分期与长链非编码lncRNA表达的相关性研究<sup> </sup></title><p>高希春，钱军<sup>*</sup>，魏铭，徐星榕，汪如荣，辛向斌</p><p>河西学院附属张掖人民医院，甘肃 张掖</p><disp-formula id="hanspub.32681-formula28"><graphic xlink:href="//html.hanspub.org/file/2-2150181x5_hanspub.png"  xlink:type="simple"/></disp-formula><p>收稿日期：2019年10月4日；录用日期：2019年10月21日；发布日期：2019年10月28日</p><disp-formula id="hanspub.32681-formula29"><graphic xlink:href="//html.hanspub.org/file/2-2150181x6_hanspub.png"  xlink:type="simple"/></disp-formula></sec><sec id="s2"><title>摘 要</title><p>目的：探讨长链非编码RNA(long noncoding RNA, lncRNA)中的lncRNA-19、FER1L4、LINC00152及AK054979在胃癌组织的表达。方法：收集24例胃癌患者癌组织，采用实时荧光定量PCR测定胃癌组织、癌旁组织及正常组织中lncRNA-19、FER1L4、LINC00152及AK054979的表达水平，分析lncRNA-19、FER1L4、LINC00152及AK054979表达与胃癌组织表达的相关性。结果：胃癌组织中lncRNA-19、FER1L4、LINC00152及AK054979的表达水平呈高表达(P均 &lt; 0.01)；且与胃癌临床病理分期呈正相关(P &lt; 0.05)。结论：lncRNA-19、FER1L4、LINC00152及AK054979在胃癌组织中均高表达，且与胃癌病理分期呈正相关。</p><p>关键词 :胃癌，长链非编码RNA，lncRNA-19，FER1L4，LINC00152，AK054979</p><disp-formula id="hanspub.32681-formula30"><graphic xlink:href="//html.hanspub.org/file/2-2150181x7_hanspub.png"  xlink:type="simple"/></disp-formula><p>Copyright &#169; 2019 by author(s) and Hans Publishers Inc.</p><p>This work is licensed under the Creative Commons Attribution International License (CC BY).</p><p>http://creativecommons.org/licenses/by/4.0/</p><p><img src="//html.hanspub.org/file/2-2150181x8_hanspub.png" /> <img src="//html.hanspub.org/file/2-2150181x9_hanspub.png" /></p></sec><sec id="s3"><title>1. 引言</title><p>胃癌是危害人类健康的最常见癌症之一，根据Globocan数据库，胃癌是全球第五个最常见的癌症，在男性中甚至排在第4位，在女性中排在第5位，也是全球癌症相关死亡的第三大原因 [<xref ref-type="bibr" rid="hanspub.32681-ref1">1</xref>] [<xref ref-type="bibr" rid="hanspub.32681-ref2">2</xref>] 。自从2010年以来，癌症成为我国疾病死亡的首要原因，严重威胁人们的健康和生命，并已成为全球的癌症负担。新近研究发现长链非编码RNA (long non-coding RNA, lncRNA)在包括胃癌等多种癌症中异常表达，为探索肿瘤发生机制、寻找新标志物和治疗靶点提供了新机遇。lncRNA是一种长度超过200个核苷酸(nucleotide, nt)的非编码RNA，在细胞核中，lncRNA具有正负调控转录、调整细胞核的亚显微结构、介导染色体相互作用的功能。多项研究表明lncRNA既可起引发癌基因的作用，促进恶性肿瘤的发生、发展，也可起抑癌基因的作用 [<xref ref-type="bibr" rid="hanspub.32681-ref3">3</xref>] [<xref ref-type="bibr" rid="hanspub.32681-ref4">4</xref>] [<xref ref-type="bibr" rid="hanspub.32681-ref5">5</xref>] 。Liu等通过qRT-PCR监测组织和血浆中的FER1L4含量，发现FER1L4的表达水平在91.8% (56/61)的胃癌组织中明显下调，并且FER1L4的低表达与肿瘤大小、组织学分型、浸润程度、淋巴侵袭、远处转移、TNM肿瘤分期、血管和神经侵袭以及血清CA72-4的含量都相关 [<xref ref-type="bibr" rid="hanspub.32681-ref6">6</xref>] [<xref ref-type="bibr" rid="hanspub.32681-ref7">7</xref>] 。</p><p>本研究应用实时荧光定量PCR法检测胃癌组织中lncRNA-19、FER1L4、LINC00152及AK054979的表达情况，并进一步分析lncRNA表达与患者临床病理的关系。</p></sec><sec id="s4"><title>2. 资料与方法</title><sec id="s4_1"><title>2.1. 研究对象</title><p>收集2016年6月~2017年12月河西学院附属张掖人民医院普外及肿瘤科收治的24例胃癌患者的组织标本。24例均来自手术切除的胃癌组织。收集胃癌患者术前均未进行过化疗、放疗治疗和免疫治疗等其他治疗方案。24例患者均可准确完全查找到其临床资料信息，其中包括姓名、性别、年龄、肿瘤直径、分化程度、淋巴结转移、浸润深度(见表1)、TNM分期等。排除其他部位恶性肿瘤病史；24例患者中，男性共16例，女性共8例，男女比例为2:1，年龄在42~73岁之间，中位年龄为56岁；根据国际抗癌联盟/美国癌症联合委员会胃癌TNM分期标准(2010) [<xref ref-type="bibr" rid="hanspub.32681-ref6">6</xref>] 进行TNM分期，I期6例，II期8例，III期2例，IV期4例；有淋巴结转移者14例，无淋巴结转移者10例；发生远处转移者14例，未发生远处转移者10例。胃癌组织经病理学检查确诊(见表2)。本研究经河西学院临床医学院伦理委员会批准，所有研究对象均签署知情同意书。</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Preoperative Borrmann type and pathological manifestations of gastric cance</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >MSCT大体分型</th><th align="center" valign="middle"  colspan="4"  >病理结果</th><th align="center" valign="middle"  rowspan="2"  >合计</th></tr></thead><tr><td align="center" valign="middle" >蕈伞型</td><td align="center" valign="middle" >局限溃疡型</td><td align="center" valign="middle" >浸润溃疡型</td><td align="center" valign="middle" >弥漫浸润型</td></tr><tr><td align="center" valign="middle" >蕈伞型(I)</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >4</td></tr><tr><td align="center" valign="middle" >局限溃疡型(II)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >7</td></tr><tr><td align="center" valign="middle" >浸润溃疡型(III)</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >9</td></tr><tr><td align="center" valign="middle" >弥漫浸润型(IV)</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >4</td></tr><tr><td align="center" valign="middle" >合计</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >24</td></tr></tbody></table></table-wrap><p>表1. 胃癌术前Borrmann分型与病理表现对照</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Results of preoperative enhanced MSCT T staging in 24 patients with gastric cancer were compared with patholog</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >MSCT分期</th><th align="center" valign="middle"  colspan="4"  >病理分期</th></tr></thead><tr><td align="center" valign="middle" >T1</td><td align="center" valign="middle" >T2</td><td align="center" valign="middle" >T3</td><td align="center" valign="middle" >T4</td></tr><tr><td align="center" valign="middle" >T1</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >T2</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >0</td></tr><tr><td align="center" valign="middle" >T3</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >13</td><td align="center" valign="middle" >6</td></tr><tr><td align="center" valign="middle" >T4</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >7</td></tr></tbody></table></table-wrap><p>表2. 24例胃癌患者术前增强MSCT T分期结果与病理对照</p></sec><sec id="s4_2"><title>2.2. 实时荧光定量PCR法检测胃癌组织中lncRNA表达水平</title><p>应用TRIzol试剂和AMV反转录试剂盒(均为美国Invitrogen公司产品)提取胃癌组织的总RNA，并将其反转录成cDNA；以此cDNA为模板，应用2 &#215; SYBR Green PCR Master Mix试剂盒(美国Invitrogen公司产品)检测组织中lncRNA RP11-513G11.1的表达情况。</p>实验步骤<p>1) RNA提取</p><p>将样本分别用液氮研磨粉碎，加入1 ml Trizol (Invitrogen)，吸取到1.5 ml EP管中，加入500 ul酚氯仿，振荡混匀，静止5分钟，置于离心机中于4℃离心十分钟，小心吸取上层上清于一新的离心管中，加入700 ul异丙醇，混匀，于4℃ 12,000 rpm离心10分钟，小心去上清，用75%乙醇洗涤一次，晾干，溶于50 ul DEPC处理水中，电泳检测。</p><p>2) 反转录(反转录使用Invitrogen的反转录试剂盒superscript III)</p><p>按照以下体系建立反应体系(RNA均取200 ng，补水到10 ul)：</p><p>RNA 10 ul</p><p>Oligo-dT 1 ul (HOPEGENE)</p><p>Random 1 ul (HOPEGENE)</p><p>混匀，离心。65℃，5分钟，结束后置于冰上。</p><p>在上述反应体系中加入下列反应液：</p><p>dNTP (10 uM) 1ul (HOPEGENE)</p><p>0.1M DTT 2 ul</p><p>5X Buffer 4 ul</p><p>RT酶 1 ul (ABI)</p><p>混匀，离心。置于42℃，水浴60分钟。</p><p>取出后置于85℃，反应10分钟，灭活逆转录酶。反应结束后置于−20℃待用。</p><p>3) qPCR扩增</p><p>每个样本分别用待检测基因和内参基因引物扩增，每个反应做3个重复，按照以下体系建立扩增体系(20 ul)：</p><p>cDNA 2 ul</p><p>qPCR mix 10 ul</p><p>primer F 1 ul</p><p>primer R 1 ul</p><p>ddH2O 6 ul</p><p>于ABI 7900 qPCR仪上，按照以下条件反应：</p><p>95℃ 2 min</p><p>94℃ 20 s</p><p>60℃ 20 s</p><p>72℃ 30 s 40循环</p><p>根据目的基因分别设计合成引物，引物序列见列表3。</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Primer sequence lis</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Symbol</th><th align="center" valign="middle" >primer F</th><th align="center" valign="middle" >primer R</th></tr></thead><tr><td align="center" valign="middle" >actin</td><td align="center" valign="middle" >GACAGGATGCAGAAGGAGATTACT</td><td align="center" valign="middle" >TGATCCACATCTGCTGGAAGGT</td></tr><tr><td align="center" valign="middle" >lncRNA-H19</td><td align="center" valign="middle" >TGCTGCACTTTACAACCACG</td><td align="center" valign="middle" >ATGGTGTCTTTGATGTTGGGC</td></tr><tr><td align="center" valign="middle" >lncRNA-AK054979</td><td align="center" valign="middle" >ACTCTGCCTACATCGCTCTC</td><td align="center" valign="middle" >GCCACCTCTCTTCTTTCCCT</td></tr><tr><td align="center" valign="middle" >lncRNA-FER1L4</td><td align="center" valign="middle" >CCGTGTTGAGCTGCTGTTC</td><td align="center" valign="middle" >GGCAAGTCCACTGTCAGATG</td></tr><tr><td align="center" valign="middle" >lncRNA-LINC00152</td><td align="center" valign="middle" >TTGATGGCTTGAACATTTGG</td><td align="center" valign="middle" >TCG TGATTTTCGGTGTCTGT</td></tr></tbody></table></table-wrap><p>表3. 引物序列表</p><p>所有引物为美国Invitrogen公司产品。PCR反应条件：95℃ 20 s；95 ℃ 10 s、60℃ 20 s，共40个循环。</p></sec><sec id="s4_3"><title>2.3. 统计学方法</title><p>应用SPSS18.0统计软件包处理数据，对研究的结果数据进行统计分析。结果以均数&#177;标准误差(mean &#177; SD)表示，采用配对t检验进行两样本均数之间的比较，P &lt; 0.05认为差异具有统计学意义。胃癌组织中lncRNA-19、FER1L4、LINC00152及AK054979的表达与胃癌患者临床病理参数之间的关系采用X<sup>2</sup>检验。P &lt; 0.05表示差异有统计学意义。</p></sec></sec><sec id="s5"><title>3. 结果</title><p>釆用北京华普奥科生物科技有限公司基因芯片，对胃癌肿瘤组织标本中筛选出lncRNA-19、FER1L4、LINC00152及AK054979四种高表达lncRNA检测基因。然后应用实时荧光定量PCR法检测24例胃癌组织lncRNA-19、FER1L4、LINC00152及AK054979的表达水平显著升高(见图1~5 QPCR结果扩增曲线及相应的溶解曲线)。课题研究显示，胃癌组织中lncRNA-19、FER1L4、LINC00152及AK054979的表达水平显著shenggao升高，均有统计学意义(P值均 &lt; 0.01)。和临床资料分析结果表明：lncRNA在胃癌组织中的表达水平与分化程度、是否淋巴结转移、TNM分期有关，其表达程度越高，分化程度也越高。</p><p>QPCR的结果：</p><p>图1. 基因Actin扩增曲线及其溶解曲线</p><p>图2. 基因lncRNA-H19扩增曲线及其溶解曲线</p><p>图3. 基因lncRNA-FER1L4扩增曲线及其溶解曲线</p><p>图4. 基因lncRNA-LINC00152扩增曲线及其溶解曲线</p><p>图5. 基因lncRNA-AK054979扩增曲线及其溶解曲线</p></sec><sec id="s6"><title>4. 讨论</title><p>癌症的发展有一个过程，以胃癌为例，经历了从癌前病变(异型增生)到早期胃癌，最后发展为进展期胃癌 [<xref ref-type="bibr" rid="hanspub.32681-ref8">8</xref>] [<xref ref-type="bibr" rid="hanspub.32681-ref9">9</xref>] 。癌前病变不但是组织发生癌变的关键性步骤，而且更为肿瘤的早期诊断和预防提供了坚实的基础。目前已有研究发现lncRNA不但在癌组织中异常表达，而且部分在癌前病变组织中也出现异常表达 [<xref ref-type="bibr" rid="hanspub.32681-ref10">10</xref>] [<xref ref-type="bibr" rid="hanspub.32681-ref11">11</xref>] [<xref ref-type="bibr" rid="hanspub.32681-ref12">12</xref>] 。与癌旁正常组织相比，lncRNA在肿瘤组织中或过表达或低表达甚至失表达，以此特异性表达来实现其调节作用，并且这种特异性表达有望成为新的肿瘤预测因子 [<xref ref-type="bibr" rid="hanspub.32681-ref13">13</xref>] [<xref ref-type="bibr" rid="hanspub.32681-ref14">14</xref>] [<xref ref-type="bibr" rid="hanspub.32681-ref15">15</xref>] [<xref ref-type="bibr" rid="hanspub.32681-ref16">16</xref>] 。Li [<xref ref-type="bibr" rid="hanspub.32681-ref17">17</xref>] 等研究发现，血浆中lncRNALINC00152对胃癌的诊断灵敏度和特异度分别为48.1%和85.2%，并能在外周血中稳定存在。</p><p>目前对于lncRNA的认识尚处在初级阶段，但已有研究发现这类分子在细胞分化、生长、新陈代谢过程及肿瘤发生中起到至关重要的作用。在分子生物学领域中，以新兴的lncRNA为代表的肿瘤表观遗传学在短短数年间得到了长足进展。H19是最早被发现的癌症相关lncRNA，它是胰岛素样生长因子2 (insulin-like growth factor2, lgf2)的印迹基因的产物，一般只在胚胎组织中出现表达，而不在成年组织中表达，但是研究发现它在组织再生或者发生肿瘤时则被重新激活。此后的研究发现，H19具有抑制癌细胞凋亡、促进癌细胞增殖、增强细胞对缺氧的耐受能力和促进新生血管出现等作用 [<xref ref-type="bibr" rid="hanspub.32681-ref16">16</xref>] [<xref ref-type="bibr" rid="hanspub.32681-ref17">17</xref>] 。随着当前癌症相关基因转录研究的迅速进展，越来越多的肿瘤相关lncRNA被发现。现阶段，对于lncRNA的研究还大多集中于组织学上，而我们则与临床密切结合，将目标聚集在血浆中的lncRNA的测定。本研究拟通过基因芯片技术筛选胃部癌相关lncRNA，发现在肿瘤组织中表达异常的lncRNA；然后运用生物信息学技术预测胃部癌相关lncRNA的靶基因，为研究lncRNA的功能、信号通路及在胃部癌发生发展中的作用奠定基础。从疾病的生物分子水平来了解和认识胃部肿瘤的生物学特征，进一步明确相关lncRNA基因在胃部癌发生和发展中的作用，以期寻找胃连接部癌早期诊断、早期治疗以及检测依据，并对肿瘤的浸润转移以及预后做出较为准确的估计。最后结合患者的临床影像病理因素，分析lncRNA与MSCT、临床病理因素的相互关系，探讨lncRNA的临床意义，以提高胃部癌的非创性诊断水平。</p></sec><sec id="s7"><title>基金项目</title><p>甘肃省高等学校科研项目资助(项目编号：2017B-37)。</p></sec><sec id="s8"><title>文章引用</title><p>高希春,钱 军,魏 铭,徐星榕,汪如荣,辛向斌. 胃癌病理分期与长链非编码lncRNA表达的相关性研究Study on the Correlation between Pathological Staging of Gastric Carcinoma and Expressions of Long-Chain Non-Coding lncRNA[J]. 世界肿瘤研究, 2019, 09(04): 110-117. https://doi.org/10.12677/WJCR.2019.94016</p></sec><sec id="s9"><title>参考文献</title></sec></body><back><ref-list><title>References</title><ref id="hanspub.32681-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">中华医学会消化内镜学分会, 中国抗癌协会肿瘤内镜专业委员会. 中国早期胃癌筛查及内镜诊治共识意见(2014年, 长沙) [J]. 中华消化内镜杂志, 2014, 31(7): 361-373.</mixed-citation></ref><ref id="hanspub.32681-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Hasegawa, S., Yoshikawa, T., et al. (2013) Esophagus or Stomach? The Seventh TNM Classification for Siewert Type II/III Juntional Adenocarcinoma. Annals of Surgical Oncology, 20, 773-779.  
https://doi.org/10.1245/s10434-012-2780-x</mixed-citation></ref><ref id="hanspub.32681-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Wapinski, O. and Chang, H.Y. (2011) Long Non-Coding RNAs and Human Disease. Trends in Cell Biology, 21, 354-361. https://doi.org/10.1016/j.tcb.2011.04.001</mixed-citation></ref><ref id="hanspub.32681-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Qi, P. and Du, X. (2013) The Long Non-Coding RNAs, a New Cancer Diagnostic and Therapeutic Gold Mine. Modern Pathology, 26, 155-165. https://doi.org/10.1038/modpathol.2012.160</mixed-citation></ref><ref id="hanspub.32681-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Gabory, A., Jammes, H. and Dandolo, L. (2010) The H19 Locus: Role of an Imprinted Non-Coding RNA in Growth and Development. BioEssays, 32, 473-480. https://doi.org/10.1002/bies.200900170</mixed-citation></ref><ref id="hanspub.32681-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">IIhan, E., Ureyen, O. and Meral, U.M. (2016) Ongoing Problems Concerning 7th TNM Staging System of Gastric Cancer. Przegląd Gastroenterologiczny, 11, 223-225. https://doi.org/10.5114/pg.2016.64069</mixed-citation></ref><ref id="hanspub.32681-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Matouk, I.J., Degrooy, N., Mezan, S., et al. (2007) The H19 Non-Coding RNA Is Essential for Human Tumor Growth. PLoS ONE, 2, e845. https://doi.org/10.1371/journal.pone.0000845</mixed-citation></ref><ref id="hanspub.32681-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Yang, F., Bi, J., Xue, X., et al. (2012) Up-Regulated Long Non-Coding RNA H19 Contributes to Proliferation of Gastric Cancer Cells. The FEBS Journal, 279, 3159-3165. https://doi.org/10.1111/j.1742-4658.2012.08694.x</mixed-citation></ref><ref id="hanspub.32681-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Gupta, R.A., Shah, N., Wang, K.C., et al. (2010) Long Non-Coding RNA HOTAIR Reprograms Chromatin State to Promote Cancer Metastasis. Nature, 464, 1071-1076. https://doi.org/10.1038/nature08975</mixed-citation></ref><ref id="hanspub.32681-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Brunner, A.L., Beck, A.H., Edris, B., et al. (2012) Transcripnal Profiling of LncRNAs and Novel Transcibed Regions across a Diverse Panel of Archived Human Cancers. Genome Biology, 13, R75.  
|https://doi.org/10.1186/gb-2012-13-8-r75</mixed-citation></ref><ref id="hanspub.32681-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Yin, D.D., Liu, Z.J., Zhang, E., et al. (2015) Decreased Expression of Long Non-Coding RNA MEG3 Affects Cell Proliferation and Predicts a Poor Prognosis in Patients with Colorectal Cancer. Tumor Biology, 36, 4851-4859. 
https://doi.org/10.1007/s13277-015-3139-2 
http://link.springer.com/10.1007/s13277-015-3139-2</mixed-citation></ref><ref id="hanspub.32681-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Fang, X.Y., Pan, H.F., Leng, R.X. and Ye, D.-Q. (2015) Long Non-Coding RNAs: Novel Insights into Gastric Cancer. Cancer Letters, 356, 357-366. https://doi.org/10.1016/j.canlet.2014.11.005</mixed-citation></ref><ref id="hanspub.32681-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Lin, X.C., Zhu, Y., Chen, W.B., et al. (2014) Integrated Analysis of Long Non-Coding RNAs and mRNA Expression Profiles Reveals the Potential Role of IncRNAs in Gastric Cancer Pathogenesis. International Journal of Oncology, 45, 619-628. https://doi.org/10.3892/ijo.2014.2431</mixed-citation></ref><ref id="hanspub.32681-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Huang, X.,Yuan, T., Tschannen, M., et al. (2013) Characterization of Human Plasma-Derived Exosomal RNAs by Deep Sequencing. BMC Genomics, 14, 319. https://doi.org/10.1186/1471-2164-14-319</mixed-citation></ref><ref id="hanspub.32681-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Gibb, F.A., Enfield, K.S., Stewart, G.L., et al. (2011) Long Non-Coding RNAs Are Expressed in Oral Mucosa and Altered in Oral Premalignant Lesions. Oral Oncology, 47, 1055-1061. https://doi.org/10.1016/j.oraloncology.2011.07.008</mixed-citation></ref><ref id="hanspub.32681-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Li, Q., Shao, Y.F., Zhang, X.J., et al. (2015) Plasma Long Noncoding RAN Protected by Exosomes as a Potenial Stable Biomarker for Gastric Cancer. Tumor Biology, 36, 2007-2013. https://doi.org/10.1007/s13277-014-2807-y</mixed-citation></ref><ref id="hanspub.32681-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Song, H., Sun, W., Ye, G., et al. (2013) Long Non-Coding RNA Expression Profile in Human Gastric Cancer and Its Clinical Significances. Journal of Translational Medicine, 11, 225-234. https://doi.org/10.1186/1479-5876-11-225</mixed-citation></ref></ref-list></back></article>